J. Young

A case of lichenoid drug eruption associated with relugolix

Aneesh Agarwal, V. Patel, Peter Baek, 2023, JAAD case reports.

Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment

J. Krueger, Y. Estrada, Aneesh Agarwal, 2022, Scientific Reports.

The benefit of early‐stage diagnosis: A registry‐based survey evaluating the quality of life in patients with melanoma

Emma Hill, S. Leachman, R. Samatham, 2023, Skin health and disease.

The utility of ChatGPT in generating patient-facing and clinical responses for melanoma.

B. Ungar, Ross O’Hagan, M. Levoska, 2023, Journal of the American Academy of Dermatology.

Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments

R. Rivera-Oyola, N. Gulati, D. Poplausky, 2023, Cancers.

Unique protein signatures evolve during the course of a delayed‐type hypersensitivity reaction in human skin

J. Krueger, J. Correa da Rosa, Y. Estrada, 2022, Journal of dermatology (Print).

Management of lentiginous melanoma with imiquimod assessed by reflectance confocal microscopy

R. Revankar, Peter Baek, Joseph Han, 2023, Skin Health and Disease.

No association between dupilumab use and short-term cancer development in atopic dermatitis patients.

B. Ungar, J. Correa da Rosa, E. Guttman‐Yassky, 2022, Journal of Allergy and Clinical Immunology: In Practice.